Hangzhou Financial Statements From 2010 to 2026

HNGZY Stock  USD 4.00  0.00  0.00%   
Hangzhou Tigermed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Hangzhou Tigermed's valuation are provided below:
Hangzhou Tigermed Consulting does not presently have any fundamental trends for analysis.
Check Hangzhou Tigermed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hangzhou Tigermed's main balance sheet or income statement drivers, such as , as well as many indicators such as . Hangzhou financial statements analysis is a perfect complement when working with Hangzhou Tigermed Valuation or Volatility modules.
  
This module can also supplement various Hangzhou Tigermed Technical models . Check out the analysis of Hangzhou Tigermed Correlation against competitors.

Hangzhou Tigermed Consulting Company Profit Margin Analysis

Hangzhou Tigermed's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Hangzhou Tigermed Profit Margin

    
  41.64 %  
Most of Hangzhou Tigermed's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hangzhou Tigermed Consulting is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Hangzhou Tigermed Consulting has a Profit Margin of 41.64%. This is 471.45% lower than that of the Healthcare sector and notably lower than that of the Diagnostics & Research industry. The profit margin for all United States stocks is notably lower than that of the firm.

Hangzhou Tigermed Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hangzhou Tigermed's current stock value. Our valuation model uses many indicators to compare Hangzhou Tigermed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hangzhou Tigermed competition to find correlations between indicators driving Hangzhou Tigermed's intrinsic value. More Info.
Hangzhou Tigermed Consulting is rated # 2 in return on equity category among its peers. It also is rated # 2 in return on asset category among its peers reporting about  0.29  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hangzhou Tigermed Consulting is roughly  3.41 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hangzhou Tigermed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hangzhou Tigermed's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Hangzhou Tigermed Financial Statements

Hangzhou Tigermed investors use historical fundamental indicators, such as Hangzhou Tigermed's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hangzhou Tigermed. Please read more on our technical analysis and fundamental analysis pages.
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the Peoples Republic of China and internationally. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the Peoples Republic of China. Hangzhou Tigermed operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 8299 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hangzhou Pink Sheet Analysis

When running Hangzhou Tigermed's price analysis, check to measure Hangzhou Tigermed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hangzhou Tigermed is operating at the current time. Most of Hangzhou Tigermed's value examination focuses on studying past and present price action to predict the probability of Hangzhou Tigermed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hangzhou Tigermed's price. Additionally, you may evaluate how the addition of Hangzhou Tigermed to your portfolios can decrease your overall portfolio volatility.